Vemurafenib - PDFSEARCH.IO - Document Search Engine

Vemurafenib
Results: 105

#	Item
71	SimonandJo14 cleared the room 7 days ago Add to Reading List Source URL: www.erdheim-chester.org Language: English - Date: 2014-06-13 09:50:20 Histiocytosis Syndromes Vemurafenib Magnetic resonance imaging Diabetes insipidus Health Medicine Erdheim–Chester disease
72	Clinical Thyroidology for Patients Add to Reading List Source URL: www.thyroid.org Language: English - Date: 2013-11-08 16:38:45 Oncology BRAF Papillary thyroid cancer Thyroid Cancer Sodium-iodide symporter Vemurafenib Medicine Thyroid cancer Anatomy
73	SimonandJo cleared the room 6 days ago Add to Reading List Source URL: www.erdheim-chester.org Language: English - Date: 2013-11-20 11:03:46 Sulfonamides Vemurafenib BRAF Methotrexate Biopsy San Diego Medicine Organochlorides Organofluorides
74	Microsoft Word - mMelanoma Disease Backgrounder May2013 Add to Reading List Source URL: www.roche.com Language: English - Date: 2013-05-29 02:40:11 Skin cancer BRAF Cancer Metastasis Immunotherapy Uveal melanoma DecisionDx-UM Medicine Melanoma Vemurafenib
75	NCI Workshop: Defining Clinical Utility of Molecular Diagnostics for Cancer Treatment Add to Reading List Source URL: ncifrederick.cancer.gov Language: English - Date: 2013-01-24 12:59:57 Melanoma Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Selumetinib Protein kinase inhibitor Erlotinib Chemistry Organic chemistry Medicine
76	NEW THERAPIES GIVING HOPE FOR PATIENTS WITH ADVANCED MELANOMA Cutting-edge treatments represent recent surge in research aimed at battling melanoma Denver March 21, 2014 Add to Reading List Source URL: www.pwrnewmedia.com Language: English - Date: 2014-03-20 21:37:51 Ipilimumab Vemurafenib Immunotherapy Skin cancer BRAF Targeted therapy Cancer Chemotherapy Uveal melanoma Medicine Cancer treatments Melanoma
77 $NCI Protocol #: PBTC-029 Local Protocol #: PBTC-029B Version date: 29 October 2013 Protocol Abstract and Schema A Phase 1 and Phase II Study of AZD6244 for Recurrent or Refractory Pediatric Low$	NCI Protocol #: PBTC-029 Local Protocol #: PBTC-029B Version date: 29 October 2013 Protocol Abstract and Schema A Phase 1 and Phase II Study of AZD6244 for Recurrent or Refractory Pediatric Low Add to Reading List Source URL: www.pbtc.org Language: English - Date: 2013-12-04 15:53:18 Chemistry Pilocytic astrocytoma Glioma Astrocytoma Selumetinib Vemurafenib BRAF Neurofibromatosis type I Brain tumor Medicine Oncology
78	PRIOR AUTHORIZATION POLICY Mekinist™ (trametinib tablets – GlaxoSmithKline) To Initiate a Coverage Review, Call[removed]OVERVIEW Mekinist is a kinase inhibitor indicated for the treatment of patients with unre Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2014-01-29 12:46:55 Organofluorides Sulfonamides Vemurafenib Chemistry Oncology BRAF Protein kinase inhibitor Metastasis Uveal melanoma Medicine Melanoma Organochlorides
79	PRIOR AUTHORIZATION POLICY Tafinlar® (dabrafenib capsules GlaxoSmithKline) To Initiate a Coverage Review, Call[removed] Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2014-01-29 12:47:05 Organofluorides Sulfonamides Vemurafenib BRAF Protein kinase inhibitor Cancer Metastasis Medicine Melanoma Organochlorides
80	PRIOR AUTHORIZATION POLICY POLICY: Zelboraf® (vemurafenib tablet Genentech/Daiichi Sankyo) Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2014-01-06 13:47:23 Organofluorides Sulfonamides Vemurafenib BRAF Protein kinase inhibitor Daiichi Sankyo Cancer Genentech Metastasis Medicine Melanoma Organochlorides